13F manager/BBIO/

Andreas Halvorsen (Viking Global) add BRIDGEBIO PHARMA INC

Andreas Halvorsen (Viking Global) add $829.9M of disclosed value in BRIDGEBIO PHARMA INC.

Signal
Investor Move
Action
Add
Capital
$829.9M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence